Alnylam Pharmaceuticals Statistics
Total Valuation
ALNY has a market cap or net worth of $62.38 billion. The enterprise value is $62.82 billion.
Important Dates
The next confirmed earnings date is Thursday, October 30, 2025, before market open.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ALNY has 131.08 million shares outstanding. The number of shares has increased by 2.84% in one year.
| Current Share Class | 131.08M |
| Shares Outstanding | 131.08M |
| Shares Change (YoY) | +2.84% |
| Shares Change (QoQ) | +0.73% |
| Owned by Insiders (%) | 0.34% |
| Owned by Institutions (%) | 98.71% |
| Float | 126.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 101.79 |
| PS Ratio | 25.18 |
| Forward PS | 13.87 |
| PB Ratio | 250.14 |
| P/TBV Ratio | 251.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 25.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.80, with a Debt / Equity ratio of 10.93.
| Current Ratio | 2.80 |
| Quick Ratio | 2.63 |
| Debt / Equity | 10.93 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.18 |
Financial Efficiency
Return on equity (ROE) is -257.82% and return on invested capital (ROIC) is -3.95%.
| Return on Equity (ROE) | -257.82% |
| Return on Assets (ROA) | -2.63% |
| Return on Invested Capital (ROIC) | -3.95% |
| Return on Capital Employed (ROCE) | -5.52% |
| Revenue Per Employee | $1.10M |
| Profits Per Employee | -$143,089 |
| Employee Count | 2,230 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 5.17 |
Taxes
| Income Tax | -60.49M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +67.09% in the last 52 weeks. The beta is 0.35, so ALNY's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +67.09% |
| 50-Day Moving Average | 460.31 |
| 200-Day Moving Average | 332.79 |
| Relative Strength Index (RSI) | 57.26 |
| Average Volume (20 Days) | 1,045,696 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ALNY had revenue of $2.46 billion and -$319.09 million in losses. Loss per share was -$2.46.
| Revenue | 2.46B |
| Gross Profit | 2.06B |
| Operating Income | -180.19M |
| Pretax Income | -379.58M |
| Net Income | -319.09M |
| EBITDA | -123.69M |
| EBIT | -180.19M |
| Loss Per Share | -$2.46 |
Full Income StatementBalance Sheet
The company has $2.86 billion in cash and $2.74 billion in debt, giving a net cash position of $117.85 million or $0.90 per share.
| Cash & Cash Equivalents | 2.86B |
| Total Debt | 2.74B |
| Net Cash | 117.85M |
| Net Cash Per Share | $0.90 |
| Equity (Book Value) | 250.59M |
| Book Value Per Share | 1.91 |
| Working Capital | 2.34B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.54 million and capital expenditures -$36.55 million, giving a free cash flow of -$52.09 million.
| Operating Cash Flow | -15.54M |
| Capital Expenditures | -36.55M |
| Free Cash Flow | -52.09M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
Gross margin is 83.64%, with operating and profit margins of -7.32% and -12.96%.
| Gross Margin | 83.64% |
| Operating Margin | -7.32% |
| Pretax Margin | -15.42% |
| Profit Margin | -12.96% |
| EBITDA Margin | -5.02% |
| EBIT Margin | -7.32% |
| FCF Margin | n/a |
Dividends & Yields
ALNY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.84% |
| Shareholder Yield | -2.84% |
| Earnings Yield | -0.51% |
| FCF Yield | -0.08% |
Dividend DetailsAnalyst Forecast
The average price target for ALNY is $466.46, which is -1.99% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $466.46 |
| Price Target Difference | -1.99% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (5Y) | 33.63% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALNY has an Altman Z-Score of 3.49 and a Piotroski F-Score of 1.
| Altman Z-Score | 3.49 |
| Piotroski F-Score | 1 |
